Most Read

  1. Pneumococcal Vaccine as One of the Immunization Coverage Targets for Adulthood Vaccines: A Consensus Report of the Study Group for Adult Immunization of the Turkish Society of Clinical Microbiology and Infectious Diseases
  2. HIV Infection in Turkey: How Close Are We to the Target?
  3. Does Hepatitis B Affect Erectile Dysfunction and Lower Urinary Tract Symptoms?
  4. Is Ceftriaxone and Metronidazole Combination Effective in the Empirical Therapy of Intra-Abdominal Infections?
  5. When to Stop Antiviral Therapy in Chronic Hepatitis B
  6. Evaluation of HBeAg-Negative Chronic Hepatitis B Patients Who Had Undergone Liver Biopsy in Accordance With the Guidelines
  7. Crimean-Congo Haemorrhagic Fever: Treatment and Use of Ribavirin
  8. Analysis of HIV/AIDS-Related Stigma and Discrimination in Turkey: Results of the People Living With HIV Stigma Index
  9. Diagnosis, Treatment and Prevention of Diabetic Foot Wounds and Infections: Turkish Consensus Report
  10. Parotitis Cases Due to Measles-Mumps-Rubella Vaccine
  11. Mycoplasma hominis and Ureaplasma urealyticum: Their Role in Urogenital System Infections and Retrospective Evaluation of Antibiotic Resistance Rates
  12. Modern Diagnostic Methods Used in Bacteriology: Rapid and Effective

Volume 39, Issue 3

Original Article

Baseline Risk Factors for Hepatotoxicity During Latent Tuberculosis Prophylaxis: A Retrospective Cohort Study

Mert Üğe
Affiliations
  • Manisa Celal Bayar Üniversitesi Tıp Fakültesi, Hafsa Sultan Hastanesi, Manisa, Türkiye
https://orcid.org/0000-0002-3055-0455
,
Şahin Can Özaltun
Affiliations
  • https://orcid.org/0000-0002-0932-5253 Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Ankara, Türkiye
https://orcid.org/0000-0002-0932-5253
  • hepatotoxicity
  • isoniazid
  • Latent tuberculosis infection
  • prophylaxis
  • proplıyfaxis
  • rifampin

Abstract

Objective: This study aimed to determine the incidence of hepatotoxicity in patients receiving latent tuberculosis infection (LTBI) prophylaxis and to evaluate the independent roles of baseline biochemical markers in predicting hepatotoxicity.

Methods: This retrospective cohort study included 613 adults who received prophylactic treatment for LTBI at the Tuberculosis Control Unit of the Karabük Provincial Health Directorate, Türkiye, between January 1, 2018, and December 31, 2024. Demographic characteristics, clinical indications, and baseline laboratory parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin, glucose, and lipid profile, were evaluated. Univariate and multivariable logistic regression analyses were performed to identify independent predictors of hepatotoxicity occurring within the first month of treatment.

Results: Hepatotoxicity developed in 39 patients (6.3%) during the first month of treatment. In the univariate analysis, hepatotoxicity was significantly associated with nationality (p=0.03), whereas age group showed a borderline association (p=0.06); no significant association was observed with sex. Baseline ALT, AST, ALP, GGT, and bilirubin levels were significantly higher among patients who developed hepatotoxicity (all p<0.05). In the multivariable analysis, baseline ALT (OR 1.04), ALP (OR 1.01), age ≥41 years (OR 2.16), and total bilirubin (OR 5.00) were identified as independent predictors of hepatotoxicity. The model demonstrated a good fit to the data (Hosmer-Lemeshow p=0.415). The area under the curve (AUC) was 0.780 (95% CI 0.707–0.853).

Conclusion: Baseline ALT, ALP, and total bilirubin levels, together with age ≥41 years, were independent predictors of early hepatotoxicity during LTBI prophylaxis. These findings suggest that these parameters may contribute to pretreatment assessment of hepatotoxicity risk and the development of individualized monitoring strategies.

  • 137-42
  • Mert Üğe
  • [email protected]
  • 10.36519/kd.2026.5546
  • February 18, 2026
  • June 5, 2026
  • September 29, 2026

  • Üğe M, Özaltun ŞC. [Baseline risk factors for hepatotoxicity during latent tuberculosis prophylaxis: A retrospective cohort study]. Klimik Derg. 2026;39(3):137–42. Turkish.
  • 25
  • 14
Download as PDF
  • This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). CC BY-NC
Volume 39, Issue 3 Volume 39, Issue 2 Volume 39, Isssue 1 Volume 38, Issue 4 Volume 38, Issue 3 Volume 38, Issue 2 Volume 38, Issue 1 Volume 37, Issue 4 Volume 37, Issue 3 Volume 37, Issue 2 Volume 37, Issue 1 Volume 36, Issue 4 Volume 36, Supplement 1 Volume 36, Issue 3 Volume 36, Issue 2 Volume 36, Issue 1 Volume 35, Issue 4 Volume 35, Issue 3 Volume 35, Issue 2 Volume 35, Issue 1 Volume 34, Issue 3 Volume 34, Issue 2 Volume 34, Issue 1 Volume 33, Issue 3 Volume 33, Issue 2 Volume 33, Issue 1 Volume 32, Issue 3 Volume 32, Supplement 1 Volume 32, Supplement 2 Volume 32, Issue 2 Volume 32, Issue 1 Volume 31, Issue 3 Volume 31, Issue 2 Volume 31, Supplement 1 Volume 31, Issue 1 Volume 30, Issue 3 Volume 30, Issue 2 Volume 30, Supplement 1 Volume 30, Issue 1 Volume 29, Issue 3 Volume 29, Issue 2 Volume 29, Issue 1 Volume 28, Supplement 1 Volume 28, Issue 3 Volume 28, Issue 2 Volume 28, Issue 1 Volume 27, Supplement 1 Volume 27, Issue 3 Volume 27, Issue 2 Volume 27, Issue 1 Volume 26, Issue 3 Volume 26, Supplement 1 Volume 26, Issue 2 Volume 26, Issue 1 Volume 25, Issue 3 Volume 25, Issue 2 Volume 25, Issue 1 Volume 24, Issue 3 Volume 24, Issue 2 Volume 24, Issue 1 Volume 23, Issue 3 Volume 23, Issue 2 Volume 23, Issue 1 Volume 22, Issue 3 Volume 22, Issue 2 Volume 22, Issue 1 Volume 21, Issue 3 Volume 21, Supplement 2 Volume 21, Supplement 1 Volume 21, Issue 2 Volume 21, Issue 1 Volume 20, Issue 3 Volume 20, Supplement 2 Volume 20, Issue 2 Volume 20, Issue 1 Volume 20, Supplement 1 Volume 19, Issue 3 Volume 19, Issue 2 Volume 19, Issue 1 Volume 18, Issue 3 Volume 18, Supplement 1 Volume 18, Issue 2 Volume 18, Issue 1 Volume 17, Issue 3 Volume 17, Issue 2 Volume 17, Issue 1 Volume 16, Issue 3 Volume 16, Issue 2 Volume 16, Issue 1 Volume 1, Supplement 1 Volume 15, Issue 3 Volume 15, Issue 2 Volume 15, Issue 1 Volume 14, Issue 3 Volume 14, Issue 2 Volume 14, Issue 1 Volume 13, Issue 3 Volume 13, Issue 2 Volume 13, Supplement 1 Volume 13, Issue 1 Volume 12, Issue 3 Volume 12, Issue 2 Volume 12, Issue 1 Volume 11, Issue 3 Volume 11, Issue 2 Volume 11, Supplement 1 Volume 11, Issue 1 Volume 10, Issue 3 Volume 10, Issue 2 Volume 10, Issue 1 Volume 9, Issue 3 Volume 9, Issue 2 Volume 9, Issue 1 Volume 8, Issue 3 Volume 8, Issue 2 Volume 8, Issue 1 Volume 6, Issue 3 Volume 7, Issue 1 Volume 7, Issue 2 Volume 7, Issue 3 Volume 4, Issue 3 Volume 5, Issue 1 Volume 5, Issue 2 Volume 5, Issue 3 Volume 6, Issue 1 Volume 6, Issue 2 Volume 3, Issue 1 Volume 3, Issue 2 Volume 3, Issue 3 Volume 4, Issue 1 Volume 4, Issue 2 Volume 1, Issue 2 Volume 2, Issue 1 Volume 2, Issue 2 Volume 2, Issue 3 Volume 1, Issue 1